Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Nutrient Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 GVR’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.9.1.1 Research Scope And Assumptions
1.10 List Of Secondary Sources
1.11 List Of Primary Sources
1.12 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape
Chapter 3 Intravenous Solutions Market Variables And Trends
3.1 Intravenous Solutions Market Lineage Outlook
3.1.1 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Growing Number Of Premature Births
3.2.1.2 Increasing Incidence Of Cancer
3.2.1.3 Increasing Risk Of Malnutrition
3.2.1.4 Growing Geriatric Population
3.2.2 Market Restraint Analysis
3.2.2.1 Shortage Of Parenteral Nutrition Products
3.2.2.2 Increased Use Of Enteral Nutrition
3.2.2.3 High Risk Of Infections
3.3 Regulatory Framework
3.3.1 Standards And Compliances
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Apac
3.3.1.4 Latin America
3.3.1.5 Mea
3.3.2 Reimbursement Scenario
3.3.2.1 U.S.
3.3.2.2 Canada
3.3.2.3 Germany
3.3.2.4 UK
3.3.2.5 Japan
3.3.2.6 Australia
3.3.2.7 China
3.4 Impact Of Covid-19 Pandemic
3.5 Industry Analysis Tools
3.5.1 Porter’s Analysis
3.5.2 Macroeconomic Analysis
Chapter 4 Intravenous Solutions Market: Product Analysis
4.1 Product Movement Analysis & Market Share, 2023 & 2030
4.2 Intravenous Solutions Market Estimates & Forecast, By Product (Revenue In USD Million And Volume In Thousand Units)
4.3 Total Parenteral Nutrition
4.3.1 Total Parenteral Nutrition Market, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
4.4 Peripheral Parenteral Nutrition
4.4.1 Peripheral Parenteral Nutrition Market, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 5 Intravenous Solutions Market: Nutrients Analysis
5.1 Nutrients Movement Analysis & Market Share, 2023 & 2030
5.2 Intravenous Solutions Market Estimates & Forecast, By Nutrients (Revenue In USD Million And Volume In Thousand Units)
5.3 Carbohydrates
5.3.1 Carbohydrates Market, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
5.4 Single-dose Amino Acid Solution
5.4.1 Single-dose Amino Acid Solution Market, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
5.5 Vitamins & Minerals
5.5.1 Vitamins & Minerals, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
5.6 Parenteral Lipid Emulsion
5.6.1 Parenteral Lipid Emulsion, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
5.7 Others
5.7.1 Others Market, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 6 Intravenous Solutions Market: Regional Estimates & Trend Analysis
6.1 Intravenous Solutions Market: Regional Outlook
6.2 North America
6.2.1 North America Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.2.2 U.S.
6.2.2.1 Key Country Dynamics
6.2.2.2 U.S. Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.2.3 Canada
6.2.3.1 Key Country Dynamics
6.2.3.2 Canada Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3 Europe
6.3.1 Europe Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.2 UK
6.3.2.1 Key Country Dynamics
6.3.2.2 UK Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.3 Germany
6.3.3.1 Key Country Dynamics
6.3.3.2 Germany Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.4 France
6.3.4.1 Key Country Dynamics
6.3.4.2 France Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.5 Italy
6.3.5.1 Key Country Dynamics
6.3.5.2 Italy Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.6 Spain
6.3.6.1 Key Country Dynamics
6.3.6.2 Spain Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.7 Denmark
6.3.7.1 Key Country Dynamics
6.3.7.2 Denmark Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.8 Sweden
6.3.8.1 Key Country Dynamics
6.3.8.2 Sweden Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.3.9 Norway
6.3.9.1 Key Country Dynamics
6.3.9.2 Norway Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4 Asia Pacific
6.4.1 Asia Pacific Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.2 Japan
6.4.2.1 Key Country Dynamics
6.4.2.2 Japan Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.3 China
6.4.3.1 Key Country Dynamics
6.4.3.2 China Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.4 India
6.4.4.1 Key Country Dynamics
6.4.4.2 India Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.5 Australia
6.4.5.1 Key Country Dynamics
6.4.5.2 Australia Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.6 South Korea
6.4.6.1 Key Country Dynamics
6.4.6.2 South Korea Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.4.7 Thailand
6.4.7.1 Key Country Dynamics
6.4.7.2 Thailand Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5 Latin America
6.5.1 Latin America Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5.2 Mexico
6.5.2.1 Key Country Dynamics
6.5.2.2 Mexico Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5.3 Brazil
6.5.3.1 Key Country Dynamics
6.5.3.2 Brazil Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.5.4 Argentina
6.5.4.1 Key Country Dynamics
6.5.4.2 Argentina Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6 Middle East & Africa (Mea)
6.6.1 Mea Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.3 South Africa
6.6.3.1 Key Country Dynamics
6.6.3.2 South Africa Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.4 Saudi Arabia
6.6.4.1 Key Country Dynamics
6.6.4.2 Saudi Arabia Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.5 UAE
6.6.5.1 Key Country Dynamics
6.6.5.2 UAE Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
6.6.6 Kuwait
6.6.6.1 Key Country Dynamics
6.6.6.2 Kuwait Intravenous Solutions Market Estimates And Forecasts, 2018 – 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 7 Competitive Analysis
7.1 Company Categorization
7.1.1 Fresenius Kabi AG
7.1.2 Pfizer Inc.
7.1.3 Otsuka Pharmaceutical Co. Ltd.
7.1.4 Baxter, B. Braun Melsungen AG
7.1.5 Vifor Pharma Management Ltd.
7.1.6 JW Life Science
7.2 Participants’ Overview
7.3 Financial Performance
7.4 Product Benchmarking
7.5 Market Participant Categorization
7.5.1 Heat Map Analysis
7.6 Company Market Share Analysis, 2022
7.7 Strategy Mapping
7.7.1 Mergers & Acquisitions
7.7.2 Product Launch
7.7.3 Partnerships & Collaborations
7.7.4 Product Approvals
7.7.5 Expansion
7.7.6 Others
Chapter 8 Analyst Perspective
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations |
